Mutant genes in familial Alzheimer's disease and transgenic models - PubMed (original) (raw)
Review
Mutant genes in familial Alzheimer's disease and transgenic models
D L Price et al. Annu Rev Neurosci. 1998.
Abstract
The most common cause of dementia occurring in mid- to late-life is Alzheimer's disease (AD). Some cases of AD, particularly those of early onset, are familial and inherited as autosomal dominant disorders linked to the presence of mutant genes that encode the amyloid precursor protein (APP) or the presenilins (PS1 or PS2). These mutant gene products cause dysfunction/death of vulnerable populations of nerve cells important in memory, higher cognitive processes, and behavior. AD affects 7-10% of individuals > 65 years of age and perhaps 40% of individuals > 80 years of age. For the late-onset cases, the principal risk factors are age and apolipoprotein (apoE) allele type, with apoE4 allele being a susceptibility factor. In this review, we briefly discuss the clinical syndrome of AD and the neurobiology/neuropathology of the disease and then focus attention on mutant genes linked to autosomal dominant familial AD (FAD), the biology of the proteins encoded by these genes, and the recent exciting progress in investigations of genetically engineered animal models that express these mutant genes and develop some features of AD.
Similar articles
- Amyotrophic lateral sclerosis and Alzheimer disease. Lessons from model systems.
Price DL, Wong PC, Borchelt DR, Pardo CA, Thinakaran G, Doan AP, Lee MK, Martin LJ, Sisodia SS. Price DL, et al. Rev Neurol (Paris). 1997 Sep;153(8-9):484-95. Rev Neurol (Paris). 1997. PMID: 9683997 Review. - Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice.
Kawasumi M, Chiba T, Yamada M, Miyamae-Kaneko M, Matsuoka M, Nakahara J, Tomita T, Iwatsubo T, Kato S, Aiso S, Nishimoto I, Kouyama K. Kawasumi M, et al. Eur J Neurosci. 2004 May;19(10):2826-38. doi: 10.1111/j.0953-816X.2004.03397.x. Eur J Neurosci. 2004. PMID: 15147316 - [Genetic factors and a polygenic model of Alzheimer's disease].
Rogaev EI. Rogaev EI. Genetika. 1999 Nov;35(11):1558-71. Genetika. 1999. PMID: 10624576 Review. Russian. - Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease.
Lahiri DK, Sambamurti K, Bennett DA. Lahiri DK, et al. Neurobiol Aging. 2004 May-Jun;25(5):651-60. doi: 10.1016/j.neurobiolaging.2003.12.024. Neurobiol Aging. 2004. PMID: 15172744 - [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
Panza F, Solfrizzi V, D'Introno A, Capurso C, Colacicco AM, Torres F, Altomare E, Capurso A. Panza F, et al. Recenti Prog Med. 2002 Sep;93(9):489-97. Recenti Prog Med. 2002. PMID: 12355988 Review. Italian.
Cited by
- Mutant presenilin 1 expression in excitatory neurons impairs enrichment-mediated phenotypes of adult hippocampal progenitor cells.
Veeraraghavalu K, Sisodia SS. Veeraraghavalu K, et al. Proc Natl Acad Sci U S A. 2013 May 28;110(22):9148-53. doi: 10.1073/pnas.1302106110. Epub 2013 May 14. Proc Natl Acad Sci U S A. 2013. PMID: 23674689 Free PMC article. - Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells.
Anandatheerthavarada HK, Biswas G, Robin MA, Avadhani NG. Anandatheerthavarada HK, et al. J Cell Biol. 2003 Apr 14;161(1):41-54. doi: 10.1083/jcb.200207030. J Cell Biol. 2003. PMID: 12695498 Free PMC article. - Attenuated hippocampus-dependent learning and memory decline in transgenic TgAPPswe Fischer-344 rats.
Ruiz-Opazo N, Kosik KS, Lopez LV, Bagamasbad P, Ponce LR, Herrera VL. Ruiz-Opazo N, et al. Mol Med. 2004 Jan-Jun;10(1-6):36-44. doi: 10.2119/2003-00044.herrera. Mol Med. 2004. PMID: 15502881 Free PMC article. - High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.
Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K, McConlogue L. Mucke L, et al. J Neurosci. 2000 Jun 1;20(11):4050-8. doi: 10.1523/JNEUROSCI.20-11-04050.2000. J Neurosci. 2000. PMID: 10818140 Free PMC article. - Cathepsin B Gene Knockout Improves Behavioral Deficits and Reduces Pathology in Models of Neurologic Disorders.
Hook G, Reinheckel T, Ni J, Wu Z, Kindy M, Peters C, Hook V. Hook G, et al. Pharmacol Rev. 2022 Jul;74(3):600-629. doi: 10.1124/pharmrev.121.000527. Pharmacol Rev. 2022. PMID: 35710131 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous